FDA approves Optilume BPH System
The minimally invasive surgical therapy is approved for the treatment of lower urinary tract symptoms secondary to BPH.
Expert highlights advancements in HoLEP for benign prostatic hyperplasia
"One of the things that made a difference, at least in my practice, was one of the newer pulse modulated holmium lasers," says Smita De, MD, PhD.
Dr. Gange discusses data on the UroLift System for BPH
The data were presented at the recent American Urological Association Annual Meeting.
FDA accepts application for tadalafil/finasteride combo capsule for BPH
Tadfin is a once-daily capsule that combines 5 mg of tadalafil (Cialis) with 5 mg of finasteride (Proscar).
CD46-targeting ADC shows promising clinical activity in mCPRC
Kiran Sury, MD, on implementing ProACT for incontinence
FDA grants 510(k) clearance to Glean Urodynamics System
The importance of federal funding in cancer research: A call to action
